Skin patch T-cell Covid vaccine to be trialled in Switzerland
The new vaccine will be administered as a tiny skin patch bristling with micro-needles that release the shot within seconds.
Keystone / Alexandra Wey
A British biotech firm is set to start clinical trials in Switzerland of a skin patch vaccine against Covid-19 that uses T-cells and could offer longer-lasting immunity than existing vaccines.
This content was published on
2 minutes
The Guardian/swissinfo/sb
Español
es
Suiza someterá a prueba vacuna COVID en parche cutáneo
Emergex announcedExternal link on Monday that it had received the green light from the Swiss drugs regulator to carry out initial human trials in Lausanne, starting January 3, 2022.
The company’s easy-to-administer skin patch vaccine primes T-cells – a group of immune cells that can target and destroy virus-infected cells – to remove infected cells from the body quickly after infection, thus preventing viral replication and disease.
Robin Cohen, Emergex’s chief commercial officer, told The GuardianExternal link newspaper: “This is the first time a regulator has approved a Covid vaccine to go into clinical trials whose sole purpose is to generate a targeted T-cell response in the absence of an antibody response and those T-cells look for infected cells and kill them.”
Current Covid-19 vaccines mainly generate an antibody response that wanes over time, which means people need booster shots to maintain protection against the virus. The Emergex vaccine works differently, by killing infected cells quickly. This means it could offer longer-lasting immunity – possibly for decades – and could also be better at fighting virus mutations, said Cohen.
The trial will be conducted by Blaise Genton, a professor at the University of Lausanne’s centre for primary care and public health. He said: “This exciting new scientific approach to developing a vaccine against Sars-CoV-2 addresses the need to generate a T-cell response to elicit long-term immunity.”
In all, 26 people will receive a high and a low dose of its experimental Covid-19 vaccine. Interim results from the trial are expected in June.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Switzerland wants to examine cooperation with the EU in the defence sector
This content was published on
The Federal Council wants to examine a security and defence partnership with the EU. Exploratory talks are to begin as soon as possible. Among other things, the partnership would be used for defence procurement.
Swiss trial shows organic farming is 85% as productive as conventional agriculture
This content was published on
This is shown by the results of a globally unique open-air trial that has been running for 47 years in Therwil in the canton of Basel-Landschaft.
Nestlé fined by Swiss canton for illegally filtered water
This content was published on
Nestlé has been fined CHF 500,000 in the canton of Vaud for the unauthorised use of activated carbon filters in the production of mineral water. The filters were used to produce Henniez water from 2008 to 2022.
Swiss government proposes restrictions on Ukrainian refugees
This content was published on
Only those whose life and limb are at risk in Ukraine and who flee to Switzerland are to be granted S status in future. The remaining Ukrainian refugees should apply for asylum. This is what the Federal Council is proposing.
This content was published on
The Fribourg parliament approved a sum of CHF6.4 million to renovate the ramparts, the walkway and the towers, as well as to replace the exterior lighting.
Swiss rental housing listings increase for the first time in three years
This content was published on
For the first time in three years, the number of advertisements for rental accommodation is on the rise, but this does not dampen demand, quite the contrary. In Ticino, the average duration of an advertisement published on the main portals is 30 days.
Switzerland doing relatively well when it comes to child vaccination rates
This content was published on
Progress in child immunisation has stalled. For decades, the number of children vaccinated against measles, polio and other diseases has risen. But since 2010, vaccination rates have stagnated in many countries, according to a study.
While Switzerland struggles to vaccinate, Portugal is already finished
This content was published on
Nowhere are more people vaccinated against Covid-19 than in Portugal, where 98% of over 25-year-olds have had both doses.
Vaccine alternative has limited impact on Covid campaign
This content was published on
The offer of a non-mRNA Covid vaccine in Switzerland has failed to speed up the government’s vaccination campaign, experts say.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.